InvestorsHub Logo
Followers 126
Posts 5457
Boards Moderated 0
Alias Born 06/09/2020

Re: antihama post# 654201

Friday, 12/08/2023 8:21:13 AM

Friday, December 08, 2023 8:21:13 AM

Post# of 719988
I wrote SARFARAZ K. NIAZI, Ph.D., SI, FRSB, FPAMS, FAACC and obviously "THE GUY" one would want to talk to regarding biosimilarity and FDAs stance on confirmatory or efficacy trials, with regards to Flaskworks Eden and the testing going on with proteomics at Advent currently and pointing him to Marnix Bosch' presentation at ASCO on method of action etc. Let's see if he is willing to shed some more light on this. Any relevant article on the subject seems to have him as author.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News